semaglutide and trevogrumab and garetosmab Regeneron's + Combination: A Game-Changer in Obesity Metabolic Disease? Honestly, F*ck this Ad :
Description
In type 2 diabetes for example, GLP-1 medicines are recommended for most only if their blood glucose is not controlled on other medications, but cardiovascular benefits have been shown in this group

2.2.3 Exclusion criteria (1) Participants with severe cardiac, cerebrovascular, hepatic, hematologic, or other life-threatening conditions

Key Takeaways Semaglutide reduces caloric intake by increasing fullness and decreasing hunger
doi: 10.1038/ejcn.2017.27 34 Bosy-WestphalASchautzBLaterWKehayiasJJGallagherDMllerMJ
.png?w=1280&max-h=720&fit=crop&auto=format)
In comparison, only 66.5% of participants taking semaglutide achieved this level of weight loss
Worth reading through before making a decision